Just Other Articles

Chapter 7 of the Bankruptcy Code supervises over the process of liquidation under the bankr

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

uptcy laws of the United States. It is the most common type of bankruptcy in the US. Chapte

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

7 bankruptcy can be filed by any one. There isn't any minimum amount that a debtor must ow

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

before filing for chapter 7. An individual debtor and a business can file Chapter 7 bankru

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

tcy. It permits debtors to release certain debts and protect their assets from creditors. H

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

wever, there are restrictions to the amount of assets that can be protected under a Chapter

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

7 bankruptcy. Often termed as liquidation bankruptcy, under Chapter 7, an individual or bus

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

iness requests the bankruptcy court to obliterate debts that are owed creating a fresh star

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

. The business? or consumers nonexempt property is sold and the earnings are used to pay of

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

creditors.

Individuals need to file for bankruptcy in a federal court under Chapter 7. In

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

a Chapter 7 bankruptcy, an individual is permitted to keep specific exempt property and mos

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

liens. Filing for Chapter 7 may be right for a person not stating child support or alimony

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

not having student loans to repay or not having recent income tax debt. Apart from this, t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

e person should not have an income less than the state median income nor should there be in

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

clusion of fines and penalties, that have been imposed for violating the law. In case of a

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

business, a company or other legal entity filing for bankruptcy under Chapter 7 is not enti

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

led to a discharge of its debts once all assets of the company have been fully dispensed. T

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e case is closed and the debts of the entity, hypothetically, continue to exist.

Filing Ch

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

pter 7 Bankruptcy has a number of advantages and disadvantages to an individual or a busine

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

s. As such, it is generally advised that adequate precautions should be taken before filing

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/90911/justotherarticles-Who-May-File-For-Chapter-7.html">Who May File For Chapter 7</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/90911/justotherarticles-Who-May-File-For-Chapter-7.html]Who May File For Chapter 7[/url]

IT consulting clients sometimes will want you to provide them credit. Don't give too much credit too soon or you'll ruin your practice in IT consulting.

It’s that time of year again. No, we’re not just talking about turkey, long lines at the mall and overnight visits with the in laws. It’s time for small business to look ahead at 2007 sales projections.

Choosing to bid on the right keywords can be key to your pay per click success. But how do you choose the proper keywords? Here are 3 powerful tips to uncovering profit-pulling keywords for your pay per click campaign...

Tags

Links

Just Other Articles - Who May File For Chapter 7

Related Articles: